Structure Therapeutics Overview
Structure Therapeutics Target Price
Analysts' 12-month price predictions for GPCR.
Get informed when a big investor buys or sells
+ FollowShare Price
$53.45
Average Target Price
$105.33
97.1% upside
97.1% upside3 analysts in the last 4 months
High: $145 | Low: $70
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-11 | H.C. WainwrightAnanda Ghosh | $70 | 31% upside |  |
| 2026-04-27 | Canaccord Genuity | $101 | 89% upside | |
| 2026-03-17 | BMO CapitalEvan Seigerman | $145 | 171.3% upside | |
| 2026-01-20 | Guggenheim | $140 | 161.9% upside | |
| 2026-01-19 | Goldman Sachs | $102 | 90.8% upside | |
| 2025-12-19 | H.C. WainwrightAnanda Ghosh | $90 | 68.4% upside | |
| 2025-12-12 | Morgan StanleyTerence Flynn | $125 | 133.9% upside | |
| 2025-12-11 | Jefferies | $125 | 133.9% upside | |
| 2025-12-08 | Stifel Nicolaus | $90 | 68.4% upside | |
| 2025-12-02 | Stifel NicolausAnnabel Samimy | $50 |  6.5% downside | |
| 2025-11-28 | H.C. WainwrightAnanda Ghosh | $60 | 12.3% upside | |
| 2024-09-23 | Morgan StanleyTerence Flynn | $118 | 120.8% upside | |
| 2024-09-10 | Piper SandlerYasmeen Rahimi | $93 | 74% upside | |
| 2024-08-09 | JMP SecuritiesJonathan Wolleben | $86 | 60.9% upside | |
| 2024-06-07 | BMO CapitalEvan Seigerman | $100 | 87.1% upside | |
| 2024-04-09 | Cantor FitzgeraldPrakhar Agrawal | $65 | 21.6% upside | |